Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 14, 2005; 11(6): 890-894
Published online Feb 14, 2005. doi: 10.3748/wjg.v11.i6.890
Published online Feb 14, 2005. doi: 10.3748/wjg.v11.i6.890
Table 2 General condition of patients at two weeks after treatment.
| HALSS group (n = 10) | Plasmapheresis group (n = 10) | Control group (n = 10) | ||||
| Pre- | Post- | Pre- | Post- | Pre- | Post- | |
| Encephalopathy | 4 | 2 | 2 | 2 | 1 | 2 |
| Ascites | 8 | 3 | 6 | 3 | 7 | 9 |
| Hepatorenal syndrome | 9 | 3 | 7 | 3 | 7 | 9 |
- Citation: Gan JH, Zhou XQ, Qin AL, Luo EP, Zhao WF, Yu H, Xu J. Hybrid artificial liver support system for treatment of severe liver failure. World J Gastroenterol 2005; 11(6): 890-894
- URL: https://www.wjgnet.com/1007-9327/full/v11/i6/890.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i6.890